Aurora Cannabis Inc (ACB) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.030x

Based on the latest financial reports, Aurora Cannabis Inc (ACB) has a cash flow conversion efficiency ratio of 0.030x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($17.00 Million) by net assets ($567.83 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ACB equity financing ratio to measure how much of total assets are equity-financed.

Aurora Cannabis Inc - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Aurora Cannabis Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Aurora Cannabis Inc (ACB) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Aurora Cannabis Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aurora Cannabis Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Forte Biosciences Inc
NASDAQ:FBRX
-0.166x
Hanyang Securities Co Ltd
KO:001755
3.040x
Lucara Diamond Corp
TO:LUC
0.083x
Site Centers Corp
NYSE:SITC
-0.013x
Astral Resources NL
AU:AAR
-0.011x
Byggma
OL:BMA
-0.001x
Kolibri Global Energy Inc. Common stock
NASDAQ:KGEI
0.065x
Galectin Therapeutics Inc
NASDAQ:GALT
0.030x

Annual Cash Flow Conversion Efficiency for Aurora Cannabis Inc (2007–2025)

The table below shows the annual cash flow conversion efficiency of Aurora Cannabis Inc from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Aurora Cannabis Inc (ACB) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 $605.09 Million $16.00 Million 0.026x +123.28%
2024-03-31 $602.92 Million $-68.51 Million -0.114x +48.81%
2023-03-31 $521.74 Million $-115.82 Million -0.222x -5.04%
2022-03-31 $521.74 Million $-110.27 Million -0.211x -104.26%
2021-03-31 $2.04 Billion $-210.58 Million -0.103x +36.06%
2020-03-31 $2.11 Billion $-342.14 Million -0.162x -270.73%
2019-03-31 $4.40 Billion $-192.25 Million -0.044x +16.43%
2018-03-31 $1.56 Billion $-81.67 Million -0.052x +14.22%
2017-03-31 $219.71 Million $-13.38 Million -0.061x +94.84%
2016-03-31 $5.74 Million $-6.77 Million -1.180x -36.07%
2015-03-31 $3.83 Million $-3.32 Million -0.867x -22.12%
2014-03-31 $1.36 Million $-965.11K -0.710x -9.48%
2013-03-31 $690.35K $-447.84K -0.649x -152.05%
2012-03-31 $1.08 Million $-277.98K -0.257x -28.38%
2011-03-31 $1.37 Million $-275.48K -0.200x -11027.01%
2010-03-31 $1.71 Million $-3.08K -0.002x +92.54%
2009-03-31 $1.62 Million $-39.04K -0.024x +53.41%
2008-03-31 $1.68 Million $-87.26K -0.052x -677.32%
2007-03-31 $1.68 Million $15.11K 0.009x --

About Aurora Cannabis Inc

NASDAQ:ACB USA Drug Manufacturers - Specialty & Generic
Market Cap
$172.06 Million
Market Cap Rank
#17143 Global
#4010 in USA
Share Price
$2.91
Change (1 day)
+3.56%
52-Week Range
$2.58 - $6.23
All Time High
$1416.62
About

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables … Read more